Auro Laboratories
AUROLABBSE

Auro Laboratories

₹283.850.00 (0.00%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
268.00
Today’s high
292.40
52 week low
159.00
52 week high
317.00
Open price
279.95
Previous close
283.85
Live volume
--
Lower circuit
269.70
Upper circuit
298.00

Fundamentals

Market Cap
₹174Cr
ROE
2.42%
P/E Ratio(TTM)
59.06
EPS(TTM)
4.74
P/B Ratio
4.00
Dividend Yield
0.00%
Industry P/E
40.99
Book Value
69.92
Debt to Equity
1.01
Face Value
10

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About

Auro Laboratories Limited is a pharmaceutical company that commenced manufacturing activities of Active Pharmaceutical Ingredients (APIs) back in 1992. The company's governance philosophy includes core values of independence, integrity, accountability, and fairness in all its business transactions. It is also committed to enhancing shareholder value in a fair and transparent manner by benchmarking itself against the best global business practices. A key specialty is Metformin Hydrochloride, an oral drug used for managing type 2-diabetes, which the company manufactures as an API. With existing registrations and regulatory approvals, the company has an established customer base in India and various foreign countries for growth. To meet future demand, the company is doubling its Metformin HCL production from 1800 to 3600 metric tons per annum.;
MD/CEO
Mr. Sharat Deorah
Founded in
1989
BSE symbol
530233

Shareholding Pattern

Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Promoters
52.18%
Retail And Others
47.82%
Mutual Funds
0.01%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹6,282.00
0.00 (--)
L
    H
    1,68,549.9867.9910.94
    ₹2,187.70
    0.00 (--)
    L
      H
      17,957.2063.0512.7
      ₹12,574.00
      0.00 (--)
      L
        H
        16,447.0891.8210.16
        ₹827.65
        0.00 (--)
        L
          H
          12,885.78301.95
          2026
          5
          Feb
          Quarterly Result
          Release date
          2025
          12
          Nov
          Quarterly Result
          Release date
          14
          Aug
          Quarterly Result
          Release date
          30
          May
          Annual Result
          Release date
          23
          May
          Annual Result
          Release date
          14
          Feb
          Quarterly Result
          Release date
          2024
          11
          Nov
          Quarterly Result
          Release date
          9
          Aug
          Quarterly Result
          Release date
          25
          May
          Result
          Release date
          Events calendar
          View upcoming events in other stocks